UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

The lancet oncology, 2016-02, Vol.17 (2), p.153-163

2016

Volltextzugriff (PDF)

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

The lancet oncology, 2016-02, Vol.17 (2), p.200-211

2016

Volltextzugriff (PDF)

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

The lancet oncology, 2017-05, Vol.18 (5), p.599-610

2017

Volltextzugriff (PDF)

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial

The lancet oncology, 2017-05, Vol.18 (5), p.623-630

2017

Volltextzugriff (PDF)

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet (British edition), 2019-11, Vol.394 (10213), p.2012-2024

2019

Volltextzugriff (PDF)

Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis

Progress in neuro-psychopharmacology & biological psychiatry, 2021-07, Vol.109, p.110266-110266, Article 110266

2021

Volltextzugriff (PDF)

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

Journal of the American Academy of Dermatology, 2017-08, Vol.77 (2), p.310-317.e1

2017

Volltextzugriff (PDF)

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials

The lancet oncology, 2015-09, Vol.16 (9), p.1079-1089

2015

Volltextzugriff (PDF)

A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms

Journal of affective disorders, 2016-12, Vol.206, p.140-150

2016

Volltextzugriff (PDF)

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial

The lancet oncology, 2015-09, Vol.16 (9), p.1071-1078

2015

Volltextzugriff (PDF)

Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants

The American heart journal, 2019-04, Vol.210, p.18-28

2019

Volltextzugriff (PDF)

Determination of glyphosate and AMPA in blood and urine from humans: About 13 cases of acute intoxication

Forensic science international, 2013-03, Vol.226 (1), p.e20-e25

2013

Volltextzugriff (PDF)

A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

European journal of cancer (1990), 2017-05, Vol.76, p.144-151

2017

Volltextzugriff (PDF)

Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis

Gastroenterology (New York, N.Y. 1943), 2023-04, Vol.164 (4), p.642-654

2023

Volltextzugriff (PDF)

Dietary strategies for chemotherapy-induced nausea and vomiting: A systematic review

Clinical nutrition (Edinburgh, Scotland), 2022-10, Vol.41 (10), p.2147-2155

2022

Volltextzugriff (PDF)

Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review

Critical reviews in oncology/hematology, 2016-03, Vol.99, p.13-36

2016

Volltextzugriff (PDF)

Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma

European urology, 2016-02, Vol.69 (2), p.345-351

2016

Volltextzugriff (PDF)

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial

The Lancet (British edition), 2017-01, Vol.389 (10067), p.369-380

2017

Volltextzugriff (PDF)

Opioid induced nausea and vomiting

European journal of pharmacology, 2014-01, Vol.722, p.67-78

2014

Volltextzugriff (PDF)

Self-reported adverse reactions associated with mycoprotein (Quorn-brand) containing foods

Annals of allergy, asthma, & immunology, 2018-06, Vol.120 (6), p.626-630

2018

Volltextzugriff (PDF)

Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO)

European journal of cancer (1990), 2022-05, Vol.166, p.126-133

2022

Volltextzugriff (PDF)

The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting

European journal of pharmacology, 2014-01, Vol.722, p.48-54

2014

Volltextzugriff (PDF)

Anticipatory nausea and vomiting due to chemotherapy

European journal of pharmacology, 2014-01, Vol.722, p.172-179

2014

Volltextzugriff (PDF)

Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids

Fertility and sterility, 2015-02, Vol.103 (2), p.519-527.e3

2015

Volltextzugriff (PDF)

Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study

Journal of pain and symptom management, 2014-05, Vol.47 (5), p.839-848.e4

2014

Volltextzugriff (PDF)

1 – 25 von 1.319

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.294)
Mit Volltextzugriff
(1.138)

Publikationsform

Artikel
(1.318)
Tagungsberichte
(1)

Sprache

Englisch
(1.270)
Französisch
(33)
Spanisch
(19)

Erscheinungsjahr

n.n

Thema

Humans
(1.249)
Nausea - Chemically Induced
(1.094)
Life Sciences & Biomedicine
(1.067)
Science & Technology
(1.067)
Female
(851)
Male
(698)
Vomiting - Chemically Induced
(669)
Adult
(639)
Middle Aged
(586)
Biological And Medical Sciences
(433)
Aged
(417)
Medical Sciences
(408)
Pharmacology. Drug Treatments
(291)
Antineoplastic Agents - Adverse Effects
(280)
Nausea
(271)
Oncology
(267)
Antiemetics - Therapeutic Use
(211)
Nausea - Prevention & Control
(203)
Vomiting - Prevention & Control
(200)
Double-Blind Method
(199)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials

A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial

Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants

Determination of glyphosate and AMPA in blood and urine from humans: About 13 cases of acute intoxication

A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis

Dietary strategies for chemotherapy-induced nausea and vomiting: A systematic review

Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review

Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial

Opioid induced nausea and vomiting

Self-reported adverse reactions associated with mycoprotein (Quorn-brand) containing foods

Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO)

The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting

Anticipatory nausea and vomiting due to chemotherapy

Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids

Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study

Aktive Filter

Suchergebnisse filtern